Quick Order Cart

Cat. No. ARG27665

KCTD20 Knockout HAP1 Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Bone Marrow

  • Disease:

    Chronic myeloid leukemia

KCTD20 Knockout HAP1 Polyclonal Cells feature a CRISPR/Cas9-edited polyclonal knockout population in the near-haploid HAP1 cell line, targeting the KCTD20 gene, a putative substrate receptor for the Cullin3-RING E3 ubiquitin ligase complex. KCTD20 mediates protein ubiquitination and degradation, interacting with Cullin3 and RBX1. This model is ideal for ubiquitin-proteasome pathway research, substrate identification via proteomics, and functional genomics studies in a cancer cell context. Applications include co-immunoprecipitation, ubiquitination assays, and high-throughput screening to decipher KCTD20-dependent regulatory networks.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    HAP1

    Sex of Donor

    Male

    Age

    40 years

    Derived From Site

    Bone marrow

    Gene Name

    KCTD20

    Gene Identifier

    NCBI Gene ID 222658

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    IMDM

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The KCTD20 Knockout HAP1 Polyclonal Cells product consists of a polyclonal knockout cell population generated by CRISPR/Cas9-mediated disruption of the KCTD20 gene in the HAP1 human near-haploid chronic myeloid leukemia (CML) cell line. This polyclonal pool comprises a heterogeneous mixture of gene-edited cells, each carrying distinct loss-of-function mutations in KCTD20, providing a robust model for studying gene function without clonal selection. The polyclonal format preserves genetic diversity and is suitable for pooled screening applications, offering a cost-effective and scalable tool for investigating the KCTD20-dependent ubiquitin-proteasome pathway in cancer cell biology.

The HAP1 host cell line is a widely adopted model system for functional genomics, derived from the KBM-7 CML patient cell line and possessing a near-haploid karyotype. This unique genetic background facilitates efficient gene targeting and phenotype analysis, as the presence of a single allele simplifies the establishment of knockout genotypes. HAP1 cells retain key features of the myeloid lineage and are widely used in CRISPR screens, protein interaction studies, and drug target validation. Their adherent growth and robust proliferation make them suitable for a variety of cell-based assays.

KCTD20 encodes a putative substrate recognition receptor for the Cullin3-RING E3 ubiquitin ligase complex, a central component of the ubiquitin-proteasome system. Within this complex, KCTD20 likely acts as an adaptor that recruits specific protein substrates to the Cullin3 scaffold, enabling their ubiquitination by the RBX1-associated E2 enzyme and subsequent degradation by the 26S proteasome. KCTD20 function is regulated by the NEDD8 conjugation pathway, which activates Cullin3 through neddylation, and its activity is mechanistically linked to protein quality control and cell cycle progression. While its downstream targets remain largely uncharacterized, KCTD20 is hypothesized to mediate turnover of key regulatory proteins.

Loss of KCTD20 in the HAP1 near-haploid background facilitates unambiguous assessment of its role in ubiquitin-dependent degradation pathways. This knockout model allows researchers to dissect the contribution of KCTD20 to Cullin3-RING ligase activity and to identify its endogenous substrates using comparative proteomics. The HAP1 system??s genetic simplicity reduces confounding effects from paralog compensation, making it particularly valuable for mapping functional domains and for screening chemical modulators of the ubiquitin-proteasome system.

Typical applications include genomic loss-of-function screens, co-immunoprecipitation studies to validate Cullin3 interaction, ubiquitination assays, quantitative proteomics for substrate identification, and flow cytometric analysis of cell cycle and apoptosis markers. Combined with Western blotting and RT-qPCR for confirmation, this polyclonal knockout pool supports detailed mechanistic studies into KCTD20 biology. For ordering information and technical support, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)